Wednesday, December 17, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Coursera Shares Face Investor Skepticism Despite Quarterly Beat

Andreas Sommer by Andreas Sommer
November 1, 2025
in Analysis, Earnings, Nasdaq, Tech & Software
0
Coursera Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Coursera finds itself at a critical juncture as market analysts maintain a cautious stance on the educational technology firm. The investment community has settled on a consensus “Hold” recommendation, with thirteen research firms providing mixed assessments. Their collective outlook includes six “Buy” ratings balanced against six “Hold” recommendations and one “Sell” position, establishing an average price target of $12.36 per share.

Profitability Concerns Overshadow Quarterly Performance

The company’s third-quarter results demonstrated operational strength, yet failed to convince skeptics. Coursera posted adjusted earnings of $0.10 per share, exceeding the $0.09 projection from market watchers. Revenue growth remained healthy at 10.3%, pushing total sales to $194.20 million and surpassing expectations.

In response to these solid figures, management upgraded its full-year guidance. The revised forecast now anticipates 2025 revenue between $750 million and $754 million, representing a $10 million increase from previous expectations.

Analytical Divide Highlights Uncertainty

Financial institutions remain divided in their assessment despite the positive earnings surprise. Needham & Company stands firmly in the bullish camp, reiterating its “Buy” rating with a $14.00 price objective. Morgan Stanley adopted a more measured position, raising its target to $12.00 while maintaining an “Equal Weight” designation.

Should investors sell immediately? Or is it worth buying Coursera?

Bank of America shifted its perspective upward, moving from “Underperform” to “Neutral” with a $12.00 valuation. UBS followed a similar pattern, increasing its price target from $10.00 to $11.00 while keeping its “Neutral” stance. In a contrasting move, Zacks Research downgraded Coursera from “Strong Buy” to “Hold,” reflecting growing caution.

Financial Health Indicators Raise Red Flags

The core challenge for Coursera remains its inability to translate top-line growth into bottom-line results. The quarter concluded with an $8.6 million net loss, producing a negative net margin of 6.19%. Shareholder returns also suffered, with return on equity standing at -4.80%.

Further examination reveals persistent operational inefficiencies. The EBIT margin for the trailing twelve months registered at -6.9%, while the profit margin reached -7.05%. These figures indicate ongoing cost management struggles despite the company maintaining a respectable gross margin of 54.4%.

As Coursera looks toward the final quarter, management projects revenue between $189 million and $193 million. With the analytical community predominantly recommending holding positions and profitability concerns remaining unresolved, investor sentiment toward the education technology platform continues to reflect significant uncertainty.

Ad

Coursera Stock: Buy or Sell?! New Coursera Analysis from December 17 delivers the answer:

The latest Coursera figures speak for themselves: Urgent action needed for Coursera investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 17.

Coursera: Buy or sell? Read more here...

Tags: Coursera
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Biotech Balancing Act Between Promise and Financial Pressure

December 17, 2025
Microsoft Stock
AI & Quantum Computing

Microsoft Shares Surge to Unprecedented Valuation

December 17, 2025
Meta Stock
AI & Quantum Computing

Meta Faces Dual Pressure: Product Innovation Meets Senate Scrutiny

December 17, 2025
Next Post
Richardson Electronics Stock

Richardson Electronics Shares Surge on Stellar Quarterly Performance

Mosaic Stock

Mosaic Shares Under Pressure Ahead of Q3 Earnings Release

Entravision Communications Stock

Entravision Communications: A Stock at a Critical Juncture

Recommended

Finance_Banking (2)

Ally Financial Appoints Douglas Timmerman as Interim CEO Begins Search for Permanent Leader

2 years ago
Kite Realty Stock

REIT Sector Shows Signs of Revival as Kite Realty Group Gains Momentum

4 months ago
Healthcare Services Stock Exchange

Anticipation Builds for HCA Healthcares Quarterly Earnings Report

2 years ago
Work at McDonald's at 14

Heron Therapeutics Soaring to Success with Strong Q4 Results and Optimistic FY24 Guidance

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

IREN Shares Face Mounting Pressure Amid Strategic Concerns

OMV Shares Under Pressure Despite Strategic Black Sea Drilling Campaign

European Lithium Shares Reflect Divergent Investor Sentiment

Super Micro Computer Stock: A Cautionary Tale Amid Record Backlog

Regulatory Uncertainty Weighs on Lockheed Martin’s Shareholder Appeal

Palantir Secures Major Defense Contract and Strategic Consulting Alliance

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Biotech Balancing Act Between Promise and Financial Pressure

by Andreas Sommer
December 17, 2025
0

The competitive landscape for obesity treatments is heating up, fueling speculation about potential industry consolidation. At the...

Microsoft Stock

Microsoft Shares Surge to Unprecedented Valuation

December 17, 2025
Meta Stock

Meta Faces Dual Pressure: Product Innovation Meets Senate Scrutiny

December 17, 2025
IREN Stock

IREN Shares Face Mounting Pressure Amid Strategic Concerns

December 17, 2025
Omv Stock

OMV Shares Under Pressure Despite Strategic Black Sea Drilling Campaign

December 17, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Biotech Balancing Act Between Promise and Financial Pressure
  • Microsoft Shares Surge to Unprecedented Valuation
  • Meta Faces Dual Pressure: Product Innovation Meets Senate Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com